News

A Maryland man who took Ozempic and then became legally blind is suing the drug's manufacturer, arguing it had an obligation to warn patients that loss of sight could be a possible side effect. Todd ...
The Trump administration has now deported at least two children with cancer, both of whom also happen to be U.S. citizens. ( ...
HSBC analyst warns of a downside in Eli Lilly stock to $700. Rajesh Kumar cited 'valuation' as his number 1 concern.
The national advocacy group Feeding America reports that the Trump administration slashed $1 billion in federal aid to anti-hunger groups. In other nutrition news, links have been found between ...
Novo Nordisk (NVO) has launched its weight-loss drug Wegovy in Thailand, Reuters reported on Monday, citing an executive of ...
Ozempic, a popular drug for type 2 diabetes, has gained traction for its weight loss benefits, but it comes with potential ...
The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and ...
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI oncological indications announced today that it ...
Mounjaro, the new weight loss drug, is gaining popularity in India for its rapid results. Patients report better appetite control, blood sugar management, and significant weight loss.
"Oatzempic," a blend of oats, lime juice and water, has gone viral on TikTok amid claims that it supports weight loss.
The weight-loss drugs have grown in popularity, but are generally too expensive for most people to afford without insurance ...
Two years on from The Royal Gazette’s first report on a new wave of diabetes drugs with broader health benefits, the island’s ...